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ABSTRACT 
Thep53 gene family consists of three family members -p53,p63 andp73. Thep53 gene is an 
established tumour suppressor gene and functions in growth an-est, apoptosis, DNA synthesis and 
repair, genome stability and cell differenti ation. The p63 and p73 genes are involved in growth, 
development and differentiation, whereby the p63 gene is required for limb fon-nat ion and 
epidellnis fon-nati on whereas the p73 gene is essential for neurogenesis and pheromone 
signalling. In this study, p53-gene family members were amplified with RT-PCR using total 
RNA from bladder tissues. The purifIed RT -PCR products were then subjected to restriction 
digestion using Haelll , Hin 6I, Hpall, MboI, Pstl, RsaI, SmaJ, TaqI and Tru9I to obtain the RE 
site patterns for each gene family member. These pat1ems were analyzed and compared for 
variation assessment. The PCR-RFLP analysis yielded no observable results. Simulation of 
restriction digestion using MB Advanced DNA Analysis version 6.8 1 so fiwar'e showed that 
theoretically, the p53 and p73 genes showed higher similarity to each other as compared to with 
p63 gene, consistent with prev ious studies. 
Keywords:p53 gene family, RT-PCR, PCR-RFLP analysis 
ABSTRAK 
Famili gen p53 merangkumi liga ahii /amili - p53, p63 dan p 73. Gen 1'53 merupakan gen 
penindas lumor yang dikena/i dan berfimgsi dalam penghenlial1 tllmbesaran, apoplosis , simesis 
dan pemhaikan DNA, slOhilili genom dan pembezaan sel. Gen-gen p63 dan p 73 pula lerlibal 
da/am tllmhesaran, perkemhangan dan pembezaan, di mana gen p63 diperlukan unlUk 
pembenLUkan kaki, IOngan dan epidermis, semel1lara gen p73 pemi"g unluk l1ew'ogenesis dan 
pemancaran /erol11ol1. Dalam penyelidikan ini, ahii-ahii (cllnili gen p53 diamplijikasi dengan RT­
PCR dengan menggunakan RNA IOtal daripacia lisu pundi kene;ng. Produk RT-PCR yang lelah 
dill.llenlcan kemudian disu N ekkan kepada p encernaa/1 restriks i dengan menggunakan HaelII , 
Hi1161 , HpaJ], Mbal , Pst!, RsaI, Sma I, Taq! dan 1;-u91 untuk mendapatkan corak kedlldllkan RE 
lInluk seliap ahlifamili gen. Coralc tersebut dial1alisa dan dibal1dingkan unlUk penilaial1 varias i. 
Al1a/isis PCR-RFLP tidak memberikan kepulllsal1 yang dapat diperhatikan. Simulasi pencernaan 
restriksi menggunakal1 MB Advanced DNA Analysis versi 6.81 menunjukkan bahawa secara 
leori, gen-gen p53 dan p 73 menunjukkan persamaan yang lebih linggi berbanding del1gan gen 
p63. konsistel1 dengan penyelidikan sebelum ini. 
Kala kunciJamili gen p53, RT-PCR, ana lis is PCR-RFLP 
IX 
CHAPTER 1- INTRODUCTION 

The p53 gene family consists of three family members - p53, p63 and p 73. The p63 and p73 
genes were recently discovered as homo logs of the p53 gene, encoding proteins with structu ral 
and flmctional similarity to the p53 gene (Strano el al., 200 I). However, there is not much 
ev idence to support the postulated tumour suppressor role of the p63 and p73 genes due to the 
fact that they are not inactivated by mutations in a large number of cancers (Michael and Oren, 
2002). Studies on p73- and p63 -knockout mice revealed these two genes to be involved in 
growth, development and differentiation. This is because p73- and p63-deficient mice exhibit 
severe developmental diso rders and have a high rate of mortality (Davis and Dowdy, 200 I; Little 
and Jochemsen, 200 1). 
The p53 gene is an established tumour suppressor and mutated in more than 50% of human 
cancers (Kaelin , 1999). Its functions include growth arrest, apoptosis, DNA synth es is and repair, 
genome stability and ceJl di fferenti ation (D'Erchia et al., 2003). Moll et al. (200 1) stated that the 
p63 gene is required fo r limb fonn ation and epidermis fo rmation whereas the p 73 gene is 
essential fo r neur·ogenesis and pheromone signall ing. 
The p63 and p73 genes are more closely related to each other compared to with p53 (Chen, 
1999). They can also bind to p53 DNA consensus sites, transacti vate p 53 responsive genes and 
induce ce ll growth arrest or apoptos is because their gene sequence is highly simi lar with the gene 
sequence of the p 53 gene. The similari ties between the three members of the p53 gene family are 
ill us trated in Figure I. 
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Restriction endonuclease (RE) analysis is not a common method of variation analysis and has not 
been used to analyze the structural variation among the p53 gene fam il y members. However, thi s 
method has been shown to be ab le to detect genetic mutations in analysis of gastrointestulal 
cancer (Jenkills el ai. , 2002). Therefore, this project aims to determille whether RE site 
characteri zation can reliably comp are structural similarities and differences among the three 
genes in th e p53 gene famil y. Besides, this study aims to assess the structu ral or primmy 
relationship among th e p53 gene family members. 
In this project, p 53-gene famil y members were amplified with reverse-transcription polymerase 
chain reac tion (RT -PCR) using total RNA from bladder ti ssues that is avail able ill the laboratory. 
The RT -PCR products were then subjec ted to restri ction digestion to obtain the RE site patterns 
fo r each gene fam ily member. Then, these patterns was analyzed and compared to detect any 
variations. 
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Figure 1: Comparative gene SlruClUre and organ iza[ion ofp53 fam il y mem bers (TAD - transac livalion domain , 
PXXP - pro line-rich domain . DBD - DNA-bind ing domain, OD - o ligomerization doma in , SA1vl - sterile alpha 
motif domain) . Taken from Benard el a/. (2003). IPS3 Famil y Members and Human Cancers. Human !vluwfion , 2 1, 
182-t 9 L 
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CHAPTER 2 - LITERATURE REVIEW 

2.1 p53 Gene 

The p53 gene was discovered in 1979 by Levine et al. and initially thought to be an oncogene, 

due to the fact that mutated fonus o f p53 gene were fo und in tumours. However, Baker el al. 

(1989), showed that thep53 gene is actuall y a tumour suppressor gene, whereby codon 143 and 





According to Chen ( 1999), the 20 kb p53 gene, located at chro mosomal locus 17p 13. 1, codes for 
a 393 amino acid protein. It consists of II exons separated by 10 introns wi th three main 
functional domains - N-tenninal transactivation domain (TA) within residues 1-63, a ONA­
binding domain (OBO) comprising residues 100-300 and a C-telminal regul atory domain 
(residues 363-393) as depicted in Figure 2. In between these three domains are the proline-rich 
growth suppression moti fs within res idues 64-90, nuclear loca li zation signal (residues 3 16-325) 
and an oligomerization domain (00 ) within residues 33 4-356 (Chen, 1999). The promoter reg ion 
in p53 lacks the canonical consensus sequences of CAAT and TATA boxes but instead contains 
essential transcription elements and binding motifs for helix-loop-helix transcription fac tors 
(D'Erchia el aI., 2003). p53 encodes only one major transcript which produces a ubiquitously 
expressed protein with transcriptional acti vity. 
- 3 ­
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Figure 2: Organization of ulep53 gene. Taken from Irwin & Kaelin (200 1 ).p53 Family Update: p73 and p63 

Develop Their Own Identities. Cel! Growth & Difjerentiation, 12, 337-349 

The p53 gene fu nctions as a tumour suppressor gene, regulating the cell cycle, repair of DNA and 
caus ing apoptosis to damaged DNA but is not required for nonnal growth and development 
(Kaelin, 1999). Increase of intracellular levels of p53 occurs in response to cellular stress such as 
DNA damage , hypoxia or oncogene activation, leading to activation of the p53 gene (Oster et ai., 
2005). In tum, activated p53 upregulates another protein , called p21 , which is an inhibitor of 
cyclin-dependant kinases (Chen, 1999). This causes cell an'est in the G I phase of the cell cyc le, 
allowing the DNA to be repaired before replication occurs, therefore preventing damaged DNA 
from entering the S phase. G2 -M an-est is al so dependant on p53 acti vation and is induced by 
upregulation of the 14-3-3a gene by p53 (Chen, 1999). This causes the acti vation of the cyc lin-B ­
dependant cdc2 k inase, which is essential for initiation of mitos is, to be blocked by interaction of 
cdc25 phosphatase with the product of the 14-3-3a gene (Chen, 1999). 
p53 interacts with DNA helicases encoded by the xeroderma pigmenlOsa genes, XPB and XPD, to 
facilitate repair of DNA (Oster el al. , 2005). Oster et al. (2005) also states that p53 can initiate 
programmed ce ll death or apoptosis in response to radiation exposure or chemotherapeutic drugs. 
This is a mechanism of DNA damage contro l to ensure that cells that are mutated do not continue 
to propagate. Mutant p53 genes do not have the abi lity to induce apoptos is, thus resulting in 
- 4 ­
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propagation of cells containing damaged DNA, therefore caus ing tumourigenesis (Oster el 01. , 
2005). 
The p53 gene can be stabilized th ro ugh phosphorylation at Seline IS by ataxia telangiectas ia­
mutated (ATM) kinase, in response to cellular stresses, making it resistan t to ubiquitin-dependant 
proteolysis (Sutcliffe and Brehm, 2004). Chen (1999) stated that this gene is also negatively 
regulated by the human double minute 2 gene (HDM2), a homolog of the murine double minute 2 
gene (MDM2), an ubiquitin ligase which is also activated by p53. HDM2 ac ts by binding to p53 , 
thereby cause the degradation ofp53 by proteosomes, to ensure that levels ofp53 in th e cell are 
kept at low levels in the absence of stress-inducing signals (Sutcl iffe and Brehm, 2004). 
p53 has been found to be mutated in 50-60% of all human cancers (Kaelin, 1999). Chen (1999) 
stated that mutations in p53 gene are mostly missense mutations clustered in the DNA-binding 
domain accompanied by loss of heterozygosity, which in tum causes fonnation of tumours. 
Inherited p53 mutations are associated with Li-Fraumeni syndrome, an autosomal dominant 
condition in which affected individuals have a predisposition to develop cancers in several tisslles 
at a high frequency (Chen, 1999). 
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2.2p73 Gene 
The p73 gene is located on chromosomal locus I p36.33, a region frequently deleted in several 
human tumours (Kaghad et al. , 1997). It is 70 kb in size with 14 exons separated by 3 large 
introns - intron I (30 kb), intron 3 (25 kb) and intron 4 (14 kb).lt was also postulated by Kaghad 
et al. (1997) that this monoallelically expressed gene might be th e ancestral gene to p53. 
Like the p53 gene, p73 also contains an N-terminal transactivation domain (TA), DNA-binding 
domain (DBD) and an oligomelization domain (OD) showing high homology with the p53 gene 
(Kaghad el al., 1997). Kaghad el al. (1997) also found thatp 73 contains a sequence similar to the 
p53 MDM2-binding domain, allowing p73 to bind to the MDM2 protein. However, Davis and 
Dowdy (2001) staled that the interaction between MDM2 and p73 prevents its transcriptional 
function but has no effect on its stability. p73 appears to be modified by a small ubiquitin-like 
modifi er called SUMO-I that can induce degradation (Davis & Dowdy, 200 1). Besides that, the 
alpha isoform of p 73 also contains an extended C-terminal region which is made up of a sterile 
alpha motif (SAM) domain acting as an oligomerization domain invo lved in regulation of 
development (Davis & Dowdy. 1997). The promoter region ofp 73 contains a T ATA-like box and 
also transcriptional binding sites for SF1, AP2, Erg-I, Erg-2, Erg-3, E2F, Ap-2 and c-Myb (Davis 
& Dowdy, 2001). Besides that.p73 contains a second promoter at the intron 3 position producing 
N-tenninal truncated isoforms ofp73 found in mice (D 'Erchia et al., 2(03). 
- 6 ­
There are cUlTently 6 identified isofolTlls of the p 73 gene designated u, p, y, &, £ and I; (Davis & 
Dowdy, 200 1), as depicted in Figure 3. The st ructu res of the isofolTlls are as follows (Kaghad et 
al. , 1997; D'Erchi a et al., 2003): 
• 	 u-isofolTll contains all 14 exons coding for a 636 amino acid protein 
• 	 P-isoform has a shortened C-terminal derived fi'om aJtemative splicing of exon 13 coding 
for a 499 amino acid protein 
• 	 y-i soform lacks exon 11 and contains a different C-telTllinaJ reading liame coding for a 
475 amino ac id protein 
• 	 &-isofolTll lacks exon 1 I, 12 and 13 and does not have the majority of th e C-telTllinaJ 
region coding for a 404 amino acid protein 
• 	 £-isoform lacks exon II and 13 with a framesh ift in exon 12 and the C-telminal region 
composed of the gamma, foJJowed by the alpha reading frame coding for a 555 amino 
acid protein 
• 	 l;-isofOlm lacks exon II and 12 with exon 13 and 14 in the same reading frame as the 
alpha isofolm coding for a 540 amino acid protein 
- 7 ­
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Figure 3 : Organ ization of the p73 gene isoforms (TAD - transactivation domain, OBD - DNA-binding domain, 0 0 
- oligomerization domain). Taken from Benard et al. (2003). TP53 Fami ly Members and Human Cancers. Human 
Mutatiol1,21,182-191. 
This p53 homolog is involved in neurogenes rs, sensory pathways, homeostatic control, 
pheromonal signalling, natural immune response and nOlmal fluid dynamics o f cerebrospinal 
fluid and the respiratory mucosa. It is expressed at very low levels in normal human tissues and 
its expression is restli cted to ceI1ain tissues (Kaghad el ai. , 1997). According to Davi s and 
Dowdy (200 I) , p73-null mice have a high rate of mOliality caused by massive gastrointestinal 
haemorrhages and various defects such as hippocampal dysgenesis, hydrocephalus, chronic 
infections and inflammations. p73 is also able to indnce p21 w,r act ivation, similar to p53 (Kaghad 
el al., 1997). However, in the same study by Kaghad et al. (1997), p73 was found to be not 
induced by DNA-damage-activation agents that activate p53 such as actinomycln D, ultravio let 
irradi ation, gamma radiation or genotoxic agents. Neveliheless, p73 is accumulated and 
phosphorylated in response to DNA damaging agents such as cispl astin (Davis and Dowdy, 
2001). 
- 8 ­
The maternally expressed p73 gene undergoes fi'equent loss of heterozygosity (LOH) in 
neuroblastoma, breast cancer and several other cancers, which is the basis of its tumour 
suppressor gene postulation (D ' Erchia el ai. , 2003). Besides that, Kaghad el at. ( 1997) reported 
that p73 was monoallelical ly expressed due to genomic imprinting, suggesting that loss of the 
active allele may cause the loss of p 73 activity, thereby causing tumour proliferation in 
neuroblastoma. However, only wild-type p73 has been identified in human tumours thus far. 
Mutations of p73 were detec ted infrequently in human cancers, thereby challenging its tumour 
suppressor gene status (Chen, 1999). Nevertheless, highp73 expression levels have been found in 
lung, breast, bladder, neuroblastoma and hepatocellular carcinoma (Davis and Dowdy, 2001). 
2.3p63 Gene 
Thep63 gene, also known asp51 , p40,p73L, CUSP and KET, is the second homolog to the p53 
gene and a possible tumour suppressor gene (Yang el ai. , 1998; Senoo el ai. , 1998). It is located 
on chromosome 3q27-29 and predominantly in the basal layer of stratified squamous and 
transitional epithel ium in a range of human tissues (Yang el ai. , 1998). The p63 gene is 65 kb in 
size with 15 exons, having two distinct promoters for altern ative splicing (Little and Jochemsen, 
2002). Yang el ai. ( 1999) postulated that the p63 gene may be the ancestor of both p53 and p73 
due to the fact that there is a high conservation (99%) of primary amino acid proteins in human 
and murine p63. 
Like its gene family members, p63 contains three main domains, namely the transactivation 
domain erA), DNA-binding domain (DBD) and the oJigomelization domain (00). [t was 
discovered to be highly similar to 1'53 and with a higher homology to p73 (Senoo el ai., 1998). 
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However,p63 does not contain the MDM2-binding domain ofp53 (Senoo el aI., 1998). Similarly 
with p73 , only the alpha isofonns o f p63 contains the sterile alpha mo tif (SAM) domain which 
mediates protein-protein interactions (Little and Jochemsen, 2002). 
As is the case of p73 gene, p63 undergoes alternative sp licing to produce six different variants, 
three nllliength or TA isofonns and another three of these lacking the N-tenninal transactivation 
domain C6N isofonns) (Yang el al., 1998), as illustrated in Figure 4. The six isofOlIDS are 
designated T Ap63a, TAp63~, T Ap63y, 6Np63a, 6Np63~ and 6Np63y. The structures of the nIH 
length isofonn are as follows (Littl e and Jochemsen, 2002): 
• TAp63a isoforID contains all 15 exons with 641 amino acids 
• TAp63~ isofonn is derived from alternative splicing of exon 13 with 516 amino acids 
• TAp63y isofonn lacks exon 11, 12, 13 and 14 wi th 448 amino acids 
The second promoter is located inside intron 3 and transcription fi'om this end produces the three 
N-tenninal truncated iso forIDs (Little and Jochemsen, 2002): 
• 6Np63a containing 586 am ino ac ids 
• 6Np63~ conta ining 461 ami no acids 
• 6Np63y conta ining 393 am ino acids 
These N-terIDinal truncated isofonns are unable to induce transcription but act in a dominant­
negative fashion towards the transactivation acti vity of p53 and p63 with an anti-apoptotic role 
(Little and Jochemsen , 2002). 
- 10 ­
Hgure 4: Organization of the p63 gene. Taken fro m Yang el al. (2002). On the should ers of giants: p63, p73 and the 
rise of p53. Tren ds in Genetics, 18(2),90-95 . 
Regul ation of p63 is controlled by proteasomal degradation and caspase cleavage, which is 
induced by interac tion with p53 (Little and Iochemsen, 2002). However, p63 does not interac t 
and is not affec ted by MDM2 and MDMX (Little and Iochemsen, 2002). Nevertheless, the 
expression of the T A isoforms seems to be upregulated and the expression of 6N isoforms 
downregulated by DNA dam age (Little and Iochemsen, 2002). It was also found that the T A 
isoforms are able to bind to p53 -consensus sequences and further induce p53 -target genes, while 
thep63y isofOlm is found to activate cell cycle arrest and apoptosis (Little and Jochemsen, 2002). 
Besides that, p63 is also involved in the Notch signalling path way whereby the Jaggedl (fA G I) 
and Jagged2 (JAG2) genes wh ich encode Notch receptor ligands are target genes for p63 (Sasaki 
el ai., 2002). 
The p63 gene is essential in morphogenesis of epidennis, where it is predominantly expressed, 
epitheli al stem cell renewal, ep ithelial homeostas is and limb fonnation and developU1ent. 
Heterozygous ge.mline mutations in the p63 gene in humans has been associated with the rare 
autosomal dominant developmental disorder ectrodactyly, ectodermal dysplasi a, facial clefts 
(EEC), splil-hand/split-foot malfonnations (SHFM), ankyloblepharon-ec todermal dysplasia­
clefting (AEC) syndrome, limb-mammary syndrome (LMS) and acro -delmato-ungual-Iacrimal­
looth (ADULT) syndrome (van Bokhoven and Brunner, 2002). Bes ides that, heterozygous 
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missense mutations in the SAM domain have been indicated in Hay-Wells syndrome (Little and 
Jochemsen, 2002). 
However, mutation of p63 in human tumour tissues and cancer cell lines has been infrequently 
detected (Chen, 1999). In addition, the p63 gene has been found to be deleted in some bladder 
cancers and its expression amp li fied in head and neck , cervix, ovarian, sma ll cell lung carcinomas 
and basal cell carcinomas of the skin (Senoo el al., 1998; Kaelin, 1999 and Di Como el al. , 2002). 
Thus, it has been suggested that the p63 gene may be an oncogene rather than a tumour 
suppresso r gene (Little and 10chemsen. 2002). 
2.4 Reverse Transcription-Polymerase Chain Reaction CRT-PCR) 
Reverse transcription-polymerase chain reaction (RT-PCR), a highly sensitive technique to 
amplify very low copy number RNAs to detectable levels, is fi'equently used in the clinical and 
molecular biology setting for the diagnosis of genetic diseases and for quantitative determination 
of gene expression (Primrose and Twyman, 2003). 
in RT-PCR, the RNA strand undergoes reverse transcription to produce its complementary DNA 
(cDNA), which is further amplified by polymerase chain reaction (PCR) using specific primers 
(Primrose and Twyman, 2003). Reverse transcription occurs in the presence of reverse 
transcriptase, an RNA-dependent DNA polymerase found ill retroviruses (Prescott el al. , 2003). 
This produces tbe firs t strand of complementmy DNA. The second strand of DNA is then 
produced by using a deoxyoligon uc leotide primer and a DNA-d ependant DNA polymerase. The 
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RNA templ ate is degraded by RNase H, leaving behind the eDNA, which is exponentially 
amplified through peR. 
2,5 Research Rationale 
The sequences of the genes in the 1'53 gene family have been elucidated through DNA 
sequencing and are easily available through GenBank (p53, NM.OOOS46 ;p63, NM_003722;p 73 , 
NM_OOS427). Even though DNA sequenc ing may be the method of choice to determine 
sequences of genes, it is too costly and time-consuming to be used in the sc reening of human 
DNA samples, in clinical or genetic analysis (Holland and Frei, 2000). 
Restriction endonuclease analysis is another method of gene analysis, whereby the restri ction site 
pattem of a pruticular gene can be obtained and analyzed . Restriction analysis is a simple and fast 
altemative to analyze suuctural pattems of genes. Mutational studies in gastrointestinal cancer 
have also been conducted using resnict ion endonuclease analysis (J enkins el aI., 2002) . 
Therefore, the question arises as to whether restric tion endonuclease analysis is a feasi ble and 
reliable method to map the structural pattem of the p53 gene fami ly members and \0 detec t 
variations among the three genes. Since the sequences of the 1'53 gene frul1ily members ru-e well­
established in GenBank, it can be used as a reference sequence to detennine whether restri ct ion 
endonuclease ana lys is is an accurate method for gene analysis. This project aims to ascertain the 
feasibili ty of using restriction endonuclease analysis in detecting sl!uctural vari ati ons amo ng the 
1'53 gene fam ily members. 
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